Free Trial
NASDAQ:TRVN

Trevena (TRVN) Stock Price, News & Analysis

Trevena logo
$1.68 -0.08 (-4.55%)
(As of 11/22/2024 ET)

About Trevena Stock (NASDAQ:TRVN)

Key Stats

Today's Range
$1.68
$1.80
50-Day Range
$1.46
$4.95
52-Week Range
$1.13
$19.23
Volume
3,432 shs
Average Volume
5,332 shs
Market Capitalization
$1.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.

Trevena Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
25th Percentile Overall Score

TRVN MarketRank™: 

Trevena scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Trevena has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Trevena has only been the subject of 1 research reports in the past 90 days.

  • Read more about Trevena's stock forecast and price target.
  • Earnings Growth

    Earnings for Trevena are expected to grow in the coming year, from ($23.04) to ($0.90) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Trevena is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Trevena is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for TRVN.
  • Dividend Yield

    Trevena does not currently pay a dividend.

  • Dividend Growth

    Trevena does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for TRVN.
  • News Sentiment

    Trevena has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Trevena this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Trevena insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.70% of the stock of Trevena is held by insiders.

  • Percentage Held by Institutions

    Only 13.56% of the stock of Trevena is held by institutions.

  • Read more about Trevena's insider trading history.
Receive TRVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trevena and its competitors with MarketBeat's FREE daily newsletter.

TRVN Stock News Headlines

Trevena's (TRVN) Neutral Rating Reaffirmed at HC Wainwright
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
FY2024 Earnings Forecast for Trevena Issued By HC Wainwright
Research Analysts Offer Predictions for Trevena Q1 Earnings
See More Headlines

TRVN Stock Analysis - Frequently Asked Questions

Trevena's stock was trading at $18.0525 at the start of the year. Since then, TRVN stock has decreased by 90.7% and is now trading at $1.68.
View the best growth stocks for 2024 here
.

Trevena, Inc. (NASDAQ:TRVN) announced its earnings results on Thursday, November, 7th. The biopharmaceutical company reported ($5.79) earnings per share for the quarter. The biopharmaceutical company earned $0.28 million during the quarter.

Shares of Trevena reverse split on Tuesday, August 13th 2024. The 1-25 reverse split was announced on Thursday, August 8th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of TRVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trevena investors own include Novavax (NVAX), Conatus Pharmaceuticals (CNAT), Sorrento Therapeutics (SRNE), NIO (NIO), TherapeuticsMD (TXMD), Cara Therapeutics (CARA) and SCYNEXIS (SCYX).

Company Calendar

Last Earnings
11/07/2024
Today
11/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TRVN
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+197.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-40,290,000.00
Pretax Margin
-6,222.30%

Debt

Sales & Book Value

Annual Sales
$3.12 million
Book Value
($26.99) per share

Miscellaneous

Free Float
841,000
Market Cap
$1.44 million
Optionable
Optionable
Beta
1.08

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:TRVN) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners